Ceftriaxone & Tazobactam Injection 281.25 mg Supplier for Canberra, Australia
Sterile Antibiotic Injection Manufactured in India
Ernest Oncology presents Ceftriaxone & Tazobactam Injection 281.25 mg, a sterile injectable antibiotic formulation containing Ceftriaxone 250 mg and Tazobactam 31.25 mg. Manufactured in India using modern pharmaceutical technology, this injectable medicine is intended for intramuscular (IM) and intravenous (IV) administration under the supervision of qualified healthcare professionals.
Designed to meet international quality standards, the product is manufactured in WHO-GMP compliant facilities with strict quality control procedures.
Canberra Pharmaceutical Market
Australia has one of the world's most advanced healthcare systems with a strong emphasis on pharmaceutical quality, patient safety, and regulatory compliance. Healthcare providers in Canberra continue to use internationally manufactured medicines produced according to recognized pharmaceutical standards.
Indian pharmaceutical manufacturers have established a strong reputation for producing high-quality generic medicines, sterile injectables, and innovative healthcare products for global markets.
Why Choose Indian Pharmaceutical Exports
India continues to be one of the world's leading pharmaceutical manufacturing countries, supplying medicines to healthcare systems across more than 200 nations.
Benefits of Indian Pharmaceutical Manufacturing
- WHO-GMP certified production facilities
- International manufacturing practices
- Advanced pharmaceutical technology
- High-quality sterile production
- Reliable product consistency
- Affordable manufacturing capability
- Export-quality packaging
- Comprehensive quality systems
- Modern production infrastructure
- Global pharmaceutical recognition
Product Overview
| Product Details | Information |
|---|---|
| Product Name | Ceftriaxone & Tazobactam Injection |
| Total Strength | 281.25 mg |
| Composition | Ceftriaxone 250 mg + Tazobactam 31.25 mg |
| Dosage Form | Sterile Powder for Injection |
| Administration | IM / IV Use |
| Therapeutic Category | Broad-Spectrum Antibiotic |
| Packaging | Sterile Export Packaging |
| Country of Origin | India |
Key Features
- Ceftriaxone and Tazobactam combination
- Broad-spectrum antibacterial formulation
- Sterile injectable preparation
- WHO-GMP certified manufacturing
- High pharmaceutical purity
- Reliable batch consistency
- Export-quality packaging
- Stable formulation
- Suitable for clinical administration
- Manufactured under international quality standards
Recommended Dosage
The dosage should always be determined by a qualified healthcare professional.
Treatment depends on:
- Type of bacterial infection
- Severity of illness
- Patient age
- Body weight
- Kidney function
- Overall clinical condition
The medicine should never be self-administered.
Side Effects
Possible side effects include:
- Pain at the injection site
- Nausea
- Vomiting
- Diarrhea
- Headache
- Skin rash
- Fever
- Dizziness
- Allergic reactions
- Temporary liver enzyme elevation
Patients should consult their healthcare provider if symptoms persist or become severe.
Safety Information
- Prescription-only medicine.
- Use only under medical supervision.
- Inform your doctor about allergies before treatment.
- Complete the full prescribed antibiotic course.
- Follow all healthcare provider instructions.
- Do not use after the expiry date.
- Keep out of reach of children.
Product Description
Ceftriaxone & Tazobactam Injection 281.25 mg is a combination antibiotic containing Ceftriaxone, a third-generation cephalosporin antibiotic, and Tazobactam, a beta-lactamase inhibitor. Together, these active ingredients enhance antibacterial activity against susceptible bacteria.
The injection is designed for IM or IV administration by qualified healthcare professionals according to approved prescribing guidelines.
Mechanism of Action
The active ingredients work together to improve antibacterial effectiveness.
- Ceftriaxone inhibits bacterial cell wall synthesis, resulting in bacterial destruction.
- Tazobactam inhibits beta-lactamase enzymes that may reduce antibiotic effectiveness, helping Ceftriaxone maintain its antibacterial activity.
Storage Information
- Store below 25°C
- Protect from moisture
- Keep away from direct sunlight
- Store in original packaging
- Do not freeze
- Use before expiry date
Quality Assurance
Every batch supplied by Ernest Oncology is manufactured according to internationally accepted pharmaceutical quality standards.
Our Quality Commitment
- WHO-GMP certified manufacturing facilities
- Sterile production environment
- Batch quality testing
- Product traceability
- Export-grade packaging
- Controlled storage systems
- Documentation verification
- Continuous quality monitoring
Documentation
The following documents are available:
- Commercial Invoice
- Packing List
- Certificate of Analysis (COA)
- Certificate of Origin (COO)
- Product Specification Sheet
- Certificate of Pharmaceutical Product (CPP)* (where available)
- Batch Manufacturing Record*
- Airway Bill / Bill of Lading
Partner with Ernest Oncology
Ernest Oncology is dedicated to providing quality pharmaceutical products manufactured in India for healthcare markets worldwide. Our commitment focuses on innovation, pharmaceutical excellence, product safety, and internationally accepted manufacturing practices that support better healthcare outcomes.
Frequently Asked Questions (FAQs)
1. What does Ceftriaxone & Tazobactam Injection 281.25 mg contain?
It contains Ceftriaxone 250 mg and Tazobactam 31.25 mg.
2. How is this medicine administered?
It is administered by intramuscular (IM) or intravenous (IV) injection under medical supervision.
3. What is the purpose of Tazobactam?
Tazobactam inhibits beta-lactamase enzymes, helping improve the antibacterial effectiveness of Ceftriaxone.
4. How should the medicine be stored?
Store below 25°C, protected from moisture and direct sunlight.
5. Is this medicine available without a prescription?
No. It is a prescription-only medicine and should only be used under the supervision of a qualified healthcare professional.
📞 Contact Ernest Oncology — Delivering Quality Medicines Worldwide
A Trusted Healthcare Division of Ernest Pharmaceutical Pvt. Ltd.
🌐 Explore Our Healthcare Websites
- www.oncologymedicinesupplier.com
- www.ernestpharmaceuticals.com
- www.ernestvision.com
- www.ernestimpex.com
📧 Connect With Our Team
exports@ernestpharmaceuticals.com
🌍 Our Expertise
- Pharmaceutical Innovation
- Global Medicine Solutions
- International Healthcare Products
- Quality Medicines Manufactured in India
+91 93599 02383
Medical Disclaimer
- Ceftriaxone & Tazobactam Injection 562.5 mg
- Ceftriaxone & Tazobactam Injection 1125 mg
- Ceftriaxone & Sulbactam Injection 750 mg
- Ceftriaxone & Sulbactam for Injection 1.5 g
- Cefpirome Sulphate Injection 1 g (1000 mg)
Written By
Chaitali H.
B. Pharma
